💊
Cinryze
C1 inhibitor (human)
Angioedemas hereditários
✅ Autorizado
✅
Nenhum alerta ativo
Este medicamento não apresenta escassez contínua, cartas de segurança ou recolhimentos.
Para que serve
Treatment and pre-procedure prevention of angioedema attacks in adults, adolescents and children (2 years old and above) with hereditary angioedema (HAE). Routine prevention of angioedema attacks in adults, adolescents and children (6 years old and above) with severe and recurrent attacks of hereditary angioedema (HAE), who are intolerant to or insufficiently protected by oral prevention treatments, or patients who are inadequately managed with repeated acute treatment.
⚠️ Segurança do paciente
No
📚 Alertas anteriores (2)
Página oficial da EMA
https://www.ema.europa.eu/en/medicines/human/EPAR/cinryze